LATECOERE financials
LATECOERE
969500F9H7I22AX1D138 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | €258.6M | €268.8M |
| Operating profit (EBIT) | €1.8M | -€41.0M |
| Net finance income / (cost) | -€25.9M | -€14.8M |
| Income tax expense | €8.1M | €4.7M |
| Profit for the year | -€32.1M | -€60.5M |
| — attributable to owners | -€32.1M | -€60.5M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | €16.3M | -€101.8M |
| Per share | ||
| Basic EPS | €-0.00 | €-0.01 |
| Diluted EPS | €-0.00 | €-0.01 |
| Cash flow statement | ||
| Net cash from operating activities | €19.7M | -€20.1M |
| Net cash from investing activities | €11.1M | -€14.4M |
| Net cash from financing activities | -€32.9M | €9.2M |
| Proceeds from borrowings | €2.5M | €35.1M |
| Lease liability payments | €11.8M | €10.5M |
| Balance sheet | ||
| Total assets | €631.3M | €696.5M |
| Non-current assets | €209.3M | €247.8M |
| Intangible assets & goodwill | €14.2M | €18.0M |
| Current assets | €422.0M | €448.8M |
| Inventories | €232.8M | €246.4M |
| Trade & other receivables | €109.0M | €127.0M |
| Cash & equivalents | €56.8M | €59.8M |
| Total equity | €88.7M | €68.4M |
| — attributable to owners | €88.7M | €68.4M |
| Non-controlling interests | €0 | €0 |
| Non-current liabilities | €255.3M | €292.0M |
| Current liabilities | €287.3M | €336.2M |
| Trade & other payables | €165.3M | €180.2M |
| Deferred tax liabilities | €9.5M | €6.8M |
| Derived metrics | ||
| Operating margin | 0.2% | -5.8% |
| Net margin | -4.2% | -8.6% |
| Return on equity | -36.2% | -88.6% |
| Cash conversion ratio | -0.61× | 0.33× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€12.9M | -€30.8M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €19.5M | -€1.5M |
| Adjustments For Fair Value Gains Losses | €180.0K | €215.0K |
| Adjustments For Income Tax Expense | €8.1M | €4.7M |
| Adjustments For Increase Decrease In Trade and Other Payables | €8.1M | €24.3M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€9.6M | €3.6M |
| Adjustments For Sharebased Payments | €2.9M | €4.8M |
| Basic Earnings Loss Per Share From Continuing Operations | €-0.00 | €-0.01 |
| Basic Earnings Loss Per Share From Discontinued Operations | €0.00 | €0.00 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €56.7M | €59.4M |
| Cash Flows From Used In Investing Activities Discontinued Operations | €0 | €0 |
| Cash Flows From Used In Operating Activities Discontinued Operations | €0 | €0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | €10.4M | -€5.9M |
| Changes In Inventories of Finished Goods and Work In Progress | -€11.0M | -€20.7M |
| Current Contract Liabilities | €39.7M | €27.1M |
| Current Derivative Financial Assets | €11.6M | €150.0K |
| Current Derivative Financial Liabilities | €30.0K | €19.4M |
| Current Provisions | €10.6M | €9.1M |
| Current Tax Assets Current | €8.1M | €4.4M |
| Current Tax Liabilities Current | €4.2M | €3.5M |
| Deferred Tax Assets | €0 | €1.8M |
| Diluted Earnings Loss Per Share From Continuing Operations | €-0.00 | €-0.01 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €0.00 | €0.00 |
| Dividends Received Classified As Investing Activities | €2.0K | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€497.0K | -€390.0K |
| Equity and Liabilities | €631.3M | €696.5M |
| Gains Losses On Change In Fair Value of Derivatives | -€180.0K | €215.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -€11.3M | -€1.7M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €3.6M | -€23.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €249.0K | -€114.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €5.4M | €6.2M |
| Increase Decrease In Cash and Cash Equivalents | -€2.7M | -€25.7M |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €2.9M | €4.8M |
| Increase Decrease Through Transactions With Owners | €4.0M | €4.8M |
| Increase Decrease Through Treasury Share Transactions | -€3.0K | -€4.0K |
| Intangible Assets Other Than Goodwill | €95.3M | €119.9M |
| Interest Paid Classified As Financing Activities | €10.4M | €13.7M |
| Issued Capital | €127.2M | €126.2M |
| Liabilities | €542.6M | €628.2M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €0 |
| Noncurrent Derivative Financial Assets | €3.7M | €0 |
| Noncurrent Derivative Financial Liabilities | €1.4M | €16.2M |
| Noncurrent Provisions For Employee Benefits | €12.6M | €12.4M |
| Other Adjustments For Noncash Items | -€44.0K | -€8.5M |
| Other Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€18.0K | €0 |
| Other Comprehensive Income | €48.5M | -€41.2M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €49.5M | -€37.7M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €1.9M | -€3.2M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €964.0K | -€440.0K |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €45.9M | -€37.7M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €1.9M | -€3.2M |
| Other Current Assets | €3.8M | €11.1M |
| Other Current Financial Liabilities | €28.3M | €33.9M |
| Other Current Liabilities | €36.7M | €60.7M |
| Other Finance Income Cost | -€4.0M | -€693.0K |
| Other Longterm Provisions | €19.3M | €26.2M |
| Other Noncurrent Assets | €0 | €0 |
| Other Noncurrent Financial Assets | €6.4M | €6.4M |
| Other Noncurrent Liabilities | €99.0K | €6.5M |
| Other Revenue | €454.0K | €2.9M |
| Proceeds From Issuing Shares | €1.1M | €0 |
| Profit Loss From Continuing Operations | -€32.1M | -€60.5M |
| Profit Loss From Continuing Operations Attributable To Noncontrolling Interests | €0 | €0 |
| Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders of Parent Entity | -€32.1M | -€60.5M |
| Profit Loss From Discontinued Operations Attributable To Noncontrolling Interests | €0 | €0 |
| Profit Loss From Discontinued Operations Attributable To Ordinary Equity Holders of Parent Entity | €0 | €0 |
| Property Plant and Equipment Including Rightofuse Assets | €89.6M | €101.7M |
| Purchase of Financial Instruments Classified As Investing Activities | €0 | €0 |
| Reserve of Cash Flow Hedges | €9.7M | -€36.2M |
| Retained Earnings Profit Loss For Reporting Period | -€32.1M | -€60.5M |
| Revenue From Contracts With Customers | €756.7M | €705.8M |
| Share Premium | €326.1M | €326.0M |
| Tax Expense Other Than Income Tax Expense | €8.3M | €7.8M |
| Treasury Shares | €447.0K | €443.0K |
Every line item above is a fact tagged in LATECOERE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.